Loading...

BMY BRISTOL MYERS SQUIBB CO Management Changes 8-K Filing

BRST

BMY

BRISTOL MYERS SQUIBB CO

(BMY)

2026 8-K

Shareholder Meeting Results

Quarterly Results Announcement

Earnings Report

Investor Presentation Update

Tender Offer Results

Debt Offering Details

Tender Offer Announcement

Earnings Results

Financial Statements

Financial Statements

Management Change

Earnings Announcement

Q3 Earnings Report

Earnings Report

Appointment of Director

Amendment Approval

Earnings Release

Departure of Directors

Acquisition of Karuna Thera...

Offering of Notes

Management Changes

Mini-Tender Offer Rejected

Financial Results Announcement

Investor Presentation

Merger Agreement

Offering of Notes

Management Changes

Earnings Release

Share Repurchase Program

Earnings Release

Appointment of Christopher ...

Earnings Release

Management Changes

Acquisition and Contingent ...

Earnings Release

Departure of Dr. Rupert Vessey

Investor Presentation

External Links:

On May 5, 2026, Bristol Myers Squibb shareholders elected 11 directors and approved executive compensation with significant votes of around 1.5 billion for and 72 million against. Deloitte & Touche was also ratified as the accounting firm for 2026.

AI Assistant

BRISTOL MYERS SQUIBB CO

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.